血清NT-proBNP、H-FABP、VEGF-B对冠心病病情及心功能的预测价值

doi:10.3969/j.issn.1671-7171.2023.01.025

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1108 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 【目的】 探讨N末端B型利钠肽原(NT-proBNP)、心型脂肪酸结合蛋白(H-FABP)、血管内皮生长因子-B(VEGF-B)预测冠心病病情及心功能的价值。【方法】 选择两院收治的87例冠心病患者作为观察组,80例健康体检者作为对照组。比较观察组治疗前后及与对照组的NT-proBNP、H-FABP、VEGF-B水平,左心室舒张末期容积(LVEDV)、左心室收缩末期容积(LVESV)、左室射血分数(LVEF)、心输出量(CO)、心脏指数(CI)的差异,并分析观察组患者治疗前后的美国纽约心脏病学会(NYHA)心功能分级变化。【结果】 对照组的NT-proBNP、H-FABP、VEGF-B水平显著低于观察组治疗前及治疗后(P<0.05);观察组患者治疗后的NT-proBNP、H-FABP、VEGF-B水平显著低于治疗前(P<0.05)。对照组的LVEDV、LVESV、LVEF水平显著高于观察组治疗前和治疗后(P<0.05);观察组治疗后的LVEDV、LVESV、LVEF水平显著高于治疗前(P<0.05);对照组的CO、CI显著高于观察组治疗前(P<0.05),观察组治疗后的CO显著高于治疗前(P<0.05)。对照组与观察组治疗后的CO、CI水平比较,差异均无统计学意义(P>0.05)。观察组患者治疗后的心功能级别显著高于治疗前(P<0.05)。【结论】 NT-proBNP、H-FABP、VEGF-B水平的变化可预测冠心病患者病情严重程度。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	井晓
	杨妙迎

关键词 ：冠心病, 利钠肽, 脑/血液, 脂肪酸结合蛋白质3/血液, 血管内皮生长因子B/血液, 心脏功能试验

Abstract：【Objective】 To study the effects of changes in NT-proBNP,H-FABP,and VEGF-B levels on cardiac function in patients with coronary heart disease.【Methods】 Eighty-seven patients with coronary heart disease were selected as the observation group,and 80 healthy subjects were used as the control group.NT-proBNP,H-FABP,VEGF-B,left ventricular end-diastolic volume (LVEDV),left ventricular end-systolic volume (LVESV),left ventricular ejection fraction (LVEF),cardiac output,volume (CO) and cardiac index (CI) were measured before and after treatment in the observation group; And they were compared with the control group.The NYHA cardiac function grading before and after treatment in the observation group were analyzed.【Results】 The levels of NT-proBNP,H-FABP,and VEGF-B in the control group were significantly lower than those in the observation group both before treatment and after treatment.The NT-proBNP,H-FABP and VEGF-B levels in the observation group after treatment were significantly lower than those before treatment (P<0.05).The LVEDV,LVESV,and LVEF levels in the control group were significantly higher than those before treatment and after treatment in the observation group.After treatment,LVEDV,LVESV,and LVEF levels of the observation group were significantly higher than those before treatment.The CO and CI of the control group were significantly higher than those of the observation group.The CO of the observation group after treatment was significantly higher than that before treatment (P<0.05).There were no significant differences in CO and CI between the control group and the observation group (P>0.05).The cardiac function of the observation group after treatment was significantly higher than that before treatment; And the difference was statistically significant (P<0.05).【Conclusion】 Detection of changes in NT-proBNP,H-FABP,and VEGF-B levels can predict the severity of patients with coronary heart disease.

Key words： Coronary Disease Natriuretic Peptide, Brain/BL Fatty Acid Binding Protein 3/BL Vascular Endothelial Growth Factor B/BL Heart Function Tests

收稿日期: 2022-08-08

中图分类号:

R541.4

通讯作者: *,E-mail:253504787@qq.com

引用本文:

井晓, 杨妙迎. 血清NT-proBNP、H-FABP、VEGF-B对冠心病病情及心功能的预测价值[J]. 医学临床研究, 2023, 40(1): 85-87.
JING Xiao, YANG Miao-ying. Value of Serum NT-proBNP,H-FABP and VEGF-B in Predicting Coronary Heart Disease and Cardiac Function. JOURNAL OF CLINICAL RESEARCH, 2023, 40(1): 85-87.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2023.01.025 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2023/V40/I1/85

[1] 常久魁,刘晓荣,郑建辉,等.NT-proBNP与H-FABP在高血压性脑出血患者近期预后的相关性分析[J].现代生物医学进展,2016,16(16):3154-3157.
[2] 曾凯辉.右美托咪定复合七氟醚对冠心病患者非心脏手术后心肌损伤及氧化应激反应的影响[J].海南医学院学报,2017,23(18):2468-2471.
[3] 郑志君,王晓蕊,邱涛,等.参附注射液对老年慢性心衰患者血清NT-proBNP、H-FABP及CRP水平的影响[J].现代生物医学进展,2016,16(16):3134-3137.
[4] 柳彩侠,卜林,孙东.慢性心肾综合征患者外周血TnI、NT-proBNP、H-FABP及MYO水平观察[J].山东医药,2017,57(7):27-30.
[5] ANNELIEE F,ANNIKA M,ISOLDE P,et al.Reducing VEGF-B signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease[J].Cell Metab,2017,25(3):713-726.
[6] 中华医学会心血管病学分会预防学组.冠心病患者运动治疗中国专家共识[J].中华心血管病杂志,2015,43(7):575-588.
[7] 马一铭,李丽,郭涛,等.体外心脏震波对冠心病患者外周血内皮祖细胞、血管内皮生长因子和IL -8的影响及疗效评价[J].医学研究生学报,2017,30(1):42-47.
[8] 邵博一,邹建刚.白细胞水平及心型脂肪酸结合蛋白水平与冠心病心力衰竭患者心功能的相关性分析[J].医学临床研究,2016,33(10):2064-2066.
[9] JANG C,OH S F,WADA S,et al.A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.[J].Nat Med,2016,22(4):421-426.
[10] 黄兴清.抗阻运动在冠心病心力衰竭治疗中的应用研究[J].中国循证心血管医学杂志,2017,9(2):203-205.
[11] BJURMAN C,PETZOLD M,VENGE P,et al.High-sensitive cardiac troponin,NT-proBNP,hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease[J].Clin Biochem,2015,48(4-5):302-307.
[12] 杨琴,张建起,张梅,等.STEMI患者急诊PCI术前H-FABP水平与预后的关系[J].天津医药,2017,45(11):1157-1161.
[13] 陈萍,贾彦军,李杨,等.不同糖耐量人群血浆血管内皮生长因子-B水平与胰岛素抵抗的相关性研究[J].中国糖尿病杂志,2017,25(1):25-29.
[14] 黄兴清.抗阻运动在冠心病心力衰竭治疗中的应用研究[J].中国循证心血管医学杂志,2017,9(2):203-205.
[15] 陶鹏辉.hs-CRP、CTnⅠ、H-FABP及VEGF-B对急性心肌梗死早期诊断的临床价值[J].实验与检验医学,2017,35(4):585-588.